97116 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus; Retroviridae, e.g. leukemia viruses; Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
BINDER MOLECULES WITH HIGH AFFINITY AND/ OR SPECIFICITY AND METHODS OF MAKING AND USE THEREOF
#2LUMINESCENT BASED ANTIGEN ASSAY
#3ANTI-HUMAN IMMUNODEFICIENCY VIRUS-1 ANTIBODIES AND METHODS FOR USES THEREOF
#4METHODS FOR CHARACTERIZING LENTIVIRUSES
#5Methods of making active antibodies from biological fluids
#6T CELL RECEPTORS FROM THE HIV-SPECIFIC REPERTOIRE, MEANS FOR THEIR PRODUCTION AND THERAPEUTIC USES THEREOF
#7Methods of making heavy chain only antibodies using transgenic animals
#8Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats
#9CCR5 disruption of cells expressing anti-HIV chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies
#10CELL-TARGETED MOLECULES COMPRISING AMINO-TERMINUS PROXIMAL OR AMINO-TERMINAL SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS
#11Lentiviral gene transfer vectors and their medicinal applications
#12Binding molecules
#13Binding molecules
#14Inhibition of human immunodeficiency virus integrase reaching dimer formation utilizing single-chain variable antibodies
#15Bioresorbable nonlamellar microparticles and uses thereof
#16Monoclonal antibodies to human immunodeficiency virus and uses thereof
#17Monoclonal antibodies directed against the human immunodeficiency virus type 1 (hiv-1) P17 matrix (ma) protein
#18Lentiviral gene transfer vectors and their medicinal applications
#19Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
#20Detection of HIV-related proteins in urine
#21Detection of HIV-related proteins in urine
#22MONOCLONAL ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS AND USES THEREOF
#23BINDING MOLECULES
#24Anti human immunodeficiency antibodies and uses thereof
#25Lentiviral gene transfer vectors and their medicinal applications
#26Binding molecules
#27Binding molecules
#28Fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins
#29Detection of HIV-related proteins in urine
#30METHOD FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS
#31Binding molecules
#32Antibodies active against a fusion polypeptide comprising a histidine portion
#33Recombinant BCG vaccine
#34Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof
#35Adjuvant comprising non-toxic cross-linked muramyl dipeptide (MDP) microparticles derived from Propionibacterium acnes
#36Viral deconstruction through capsid assembly in vitro
#37Method for production of bioresorable microparticles, microparticles thus obtained and use thereof
#38Recombinant BCG vaccine
#39Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease
#40Diagnostic device using GP40
#41Detection of HIV-1 DNA
#42Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
#43Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
#44Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
#45Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26).
#46Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
#47Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)